Stereotaxis Clocks 28% Revenue Growth In Q2 On Continued Demand For Robotic Technology
Portfolio Pulse from Nabaparna Bhattacharya
Stereotaxis, Inc. (AMEX:STXS) reported Q2 revenues of $7.859 million, beating the analyst consensus of $6.68 million. The company delivered 28% revenue growth in the quarter, driven by a healthy system pipeline and continued demand for robotic technology. The company also announced a strategic collaboration with Abbott to integrate the EnSite X mapping system with their robotic technology. As of June 30, 2023, Stereotaxis had cash and equivalents of $23.9 million and no debt.
August 10, 2023 | 3:21 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Stereotaxis reported strong Q2 revenues, beating analyst consensus, and announced a strategic collaboration with Abbott. The company also has a healthy balance sheet with $23.9 million in cash and no debt.
Stereotaxis reported strong Q2 revenues, beating analyst consensus, which is a positive signal for investors. The strategic collaboration with Abbott could potentially open new opportunities for the company. The company's strong balance sheet with no debt also adds to investor confidence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100